Archive

Category Archive for "Pharma & Life Sciences&quot

A Google search for “healthcare innovation” returns “about 209 million” results (in 0.59 seconds). If one adds “at scale” to “healthcare innovation” the search result is a more manageable 84.4 million results. It’s clear there are a lot of people looking for innovation in healthcare. Why is Healthcare Innovation Important? There are many issues plaguing […]

A recent article written by Christina Farr identified areas of focus (and importantly, the lack thereof) of different healthcare innovators and companies as categorized in quadrants of a foursquare box. The foursquare box was created by Dr. Krishna Yeshwant, General Partner of GV, Alphabet‘s venture firm, and was a topic of conversation at HLTH 2018. Dr. […]

When a healthcare company is facing clinical shortages and rising costs, what is the solution? There are 2 options we see companies traditionally use, but *spoiler alert* we’re also going to present a 3rd! Option 1: Spend money, but ensure quality by recruiting and training nurses for non-clinical, administrative work or fill in gaps of […]

Medications. Our country can no longer live without them. Americans are living longer than ever and the correlation to the increase in prescription drug utilization may not be a coincidence. As a result, every aspect of Medication Research & Development and Medication Management focused on appropriate utilization and adherence must become more efficient and effective. […]

In 1996, World Chess Champion Garry Kasparov challenged IBM supercomputer Deep Blue in a chess match and won. But in 1997, Deep Blue defeated Kasparov in a rematch, marking the first time a computer defeated a Champion. The popularity of Freestyle Chess accelerated thereafter whereby people and computers combine in “centaur play.” Through centaur play […]

As competition and rising clinical trial costs continue to strain pharmaceutical and life sciences companies, the need to streamline processes, reduce errors, and improve quality and accuracy is greater than ever. The Data Conundrum Contract research organizations have adopted the use of eTMF platforms partly because they can provide faster study startup and cost savings. […]

Regulatory audits and inspections that result in less-than-successful marks for organizations in the pharmaceutical industry have increased in recent years—and the resulting loss of valuable time and money has begun to endanger cost structures for organizations across the industry spectrum. The Increasing Stringency of Audits The ever-increasing globalization of pharmaceutical development, research, and trials—combined with […]

Few organizations use the data they have gathered from clinical trials to improve processes. While process improvement projects are initiated with great energy, they often lose momentum and get set aside for more pressing priorities. Companies Miss Process-improvement Opportunities It is well known that trial data helps identify trends to drive process improvements throughout studies […]

Retaining top talent is one of the keys to consistent success for any company. Clinical Research Organizations (CROs) are no exception with increased pressure to maintain teams of clinicians. If you are constantly replacing vital employees, there are 4 general areas of consequence: 1. Decreased Productivity – Not only do you lose productivity once the […]

Cost and quality are often held in contention. Most would say you have to sacrifice one to get the other. Unfortunately, this has proven true in the Pharma industry as well. At both the DIA and BIO conventions, high cost of pharmaceuticals due to low quality data was a major topic. Consider some of the […]